MARKET

ATOS

ATOS

Atossa Therapeutics Inc
NASDAQ
0.7700
-0.0237
-2.99%
Closed 18:35 09/20 EDT
OPEN
0.7800
PREV CLOSE
0.7937
HIGH
0.7999
LOW
0.7700
VOLUME
277.13K
TURNOVER
--
52 WEEK HIGH
1.390
52 WEEK LOW
0.5000
MARKET CAP
96.85M
P/E (TTM)
-3.0837
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ATOS last week (0911-0915)?
Weekly Report · 3d ago
Weekly Report: what happened at ATOS last week (0904-0908)?
Weekly Report · 09/11 10:45
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 09/08 21:31
Breast Cancer-Focused Atossa Therapeutics Can Possibly Change Treatment Paradigm: Analyst
Benzinga · 09/08 18:47
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 09/08 17:31
Atossa stock jumps 16% in wake of Cantor overweight rating
Seeking Alpha · 09/08 16:29
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023
Benzinga · 09/08 15:00
Cantor Fitzgerald Initiates Coverage of Atossa Therapeutics (ATOS) with Overweight Recommendation
NASDAQ · 09/08 14:43
More
About ATOS
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing medicines in areas of unmet medical need in oncology with a focus on breast cancer. The Company’s lead drug candidate under development is oral (Z)-endoxifen, which the Company is developing in two settings: one to treat breast cancer by reducing tumor cell activity prior to surgery and another to reduce breast tissue density in women. Its programs under development include (Z)-endoxifen Programs, AT-H201, and other programs. (Z)-endoxifen is an active metabolite of tamoxifen, to treat and prevent breast cancer in high-risk women. It is developing a form of (Z)-endoxifen, which is administered orally for the potential treatment of breast cancer and reduction of breast density. AT-H201 is for lung injury caused by cancer treatments. AT-H201 consists of a combination of two drugs to treat other diseases. Its other programs include Immunotherapy/CAR-T Programs, which is in early stage of development.

Webull offers kinds of Atossa Therapeutics Inc stock information, including NASDAQ:ATOS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATOS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ATOS stock methods without spending real money on the virtual paper trading platform.